IMMUNE INTELLIGENCE

Bringing the immune system into precision medicine.
At scale, with AI.

VISION

Precision Medicine Is Revolutionizing Cancer Care. But we’re not there yet.

While immunotherapy has significantly improved patient outcomes, challenges such as variable patient responses and immune-related side effects persist. (Cancers. 2025 Feb 27;17(5):821.)

We don’t know how the patient’s immune system will respond to it.

The tumor is only half of the story.

It's not only cancer

The immune system plays a critical role in all aspects of human health

Cancer

AI-driven SaaS platform with high margins

Autoimmune diseases

Biomarkers & Assays for: Early cancer detection, Patient Therapeutic Response, Novel Drug Targets

Neurodegenerative diseases

Quality Control algorithms, Signal Optimization algorithms, LLM Clinical Data Harmonization, Biomarker Discovery, Predictive analytics

Infectious diseases

ImmunoPD response markers, Mechanism of action & resistance, Biomarkers of response prediction, Discovery of safety biomarkers, Patient selection

Age-related diseases

Support rapid international scale-up strategy, Scalable, decentralized data generation and centralized analytics

LITOSeek™

To deliver on the promise of precision medicine in oncology, we need to focus not only on the tumor but also on the immune system. To this end Novigenix has developed LITOSeek
the first immune liquid biopsy platform based on immuno-transcriptomics.

AI is revolutionizing cancer care

Our AI-enabled technology platform is at the forefront of this revolution.

The integration of artificial intelligence (AI) into oncology promises to revolutionize cancer care.

Nature Cancer. 2025;6(7):Review article.

LITOSeek™

Bringing the immune system into precision medicine. At scale, with AI

The first immune intelligence platform

LITOseek™ provides a comprehensive view of the systemic immune response

Software Platform

SaaS-first platform with real-time data harmonization, ML-driven insights, and API integration.

AI-powered immunotranscriptomics

Combines immune intelligence with tumor DNA and other omics to predict disease onset and therapy response

Oncology and beyond

Starting with cancer, immune intelligence extends to autoimmune, neurological, and other immune-driven diseases and much more

Inside the LITOSeek™ Platform

See the platform’s key features in action.

LITOSeek™

First to market AI-enabled Liquid ImmunoTranscriptOmicplatform

SOLUTIONS

It’s prime time to harness the power of RNA & AI
A single platform, diverse applications, unique insights

Overview

LITOSeek™ solutions for precision development of novel therapeutics

Immuno pharmaco-dynamic (ImmunoPD) response markers
Predictive biomarkers of response and resistance
Mechanisms of action and resistance
Discovery of safety biomarkers
Digital cytometry & cellular deconvolution
Companion diagnostic (CDx) for patient selection

Commercialized mRNA Biomarker Products in Routine Medical Practice

World´s first SaaS business model for AI-RNA

ABOUT

We are a pioneering TechBio team using our LITOSeek™ AI-RNA platform to deliver liquid biopsy multi-omic solutions that improve patient outcomes.
We are on a mission to revolutionize cancer care through early detection and targeted therapy development.

Our Journey, Your Future

We’re transforming cancer care with proven precision medicine breakthroughs.

Current LITOSeek™ Applications

Adopted Across Clinical Indications & Modalities

NEWS

Research highlights, company updates, and media coverage.
Explore the articles, videos, and perspectives behind the headlines.

Request Your Personalized Demo

See how our solution can help your business in action. Fill out the form below and we’ll get back to you shortly.